Saturday March 23, 2019
Home World Conflicting T...

Conflicting Theories About Cellphone Radiations By Two Federal Agencies

He pointed out one well-known risk from cellphones: Car crashes when drivers are distracted by them.

0
//
Mobile,cellphone
A pedestrian talking on a cellphone is silhouetted in front of a fountain in Philadelphia. VOA

Two U.S. government agencies are giving conflicting interpretations of a safety study on cellphone radiation: One says it causes cancer in rats. The other says there’s no reason for people to worry.

No new research was issued Thursday. Instead, the National Toxicology Program dialed up its concerns about a link to heart and brain cancer from a study of male rats that was made public last winter.

The Food and Drug Administration, which oversees cellphone safety, disagreed with the upgraded warning. And “these findings should not be applied to human cellphone usage,” said Dr. Jeffrey Shuren, FDA’s chief of radiological health.

What’s most important is what happens in humans, not rats, said Dr. Otis Brawley, chief medical officer of the American Cancer Society.

Cellphone
While his agency said the risks to rats don’t directly apply to people, the study raises safety questions. Pixabay

“The incidence of brain tumors in human beings has been flat for the last 40 years,” Brawley said. “That is the absolute most important scientific fact.”

The original study

In a $30 million study, scientists put rats and mice into special chambers and bombarded them with radiofrequency waves, like those emitted by older 2G and 3G phones, for nine hours a day for up to two years, most of their natural lives.

The levels the rodents experienced were far higher than people are typically exposed to.

The findings

Last February, the National Toxicology Program said there was a small increase in an unusual type of heart tumor in male rats, but not in mice or female rats. The agency concluded there was “some evidence” of a link. Also, the February report cited “equivocal evidence” of brain tumors in the male rats.

Thursday, the agency upgraded its description of those findings. The heart tumor increase marked “clear evidence” of cancer in male rats, it announced. There is “some evidence” of brain cancer.

cancer, cellphone
A radiologist examines the brain X-rays of a patient. In a small study, patients with brain tumors were given genetically modified poliovirus, which helped their bodies attack the cancer. VOA

The change came after the agency asked outside experts to analyze the findings.

“We believe that the link between radio frequency radiation and tumors in male rats is real, and the external experts agreed,” said John Bucher, the toxicology agency’s senior scientist.

While his agency said the risks to rats don’t directly apply to people, the study raises safety questions.

The disagreement

The FDA immediately disagreed, firing off a press release assuring Americans that “decades of research and hundreds of studies” has made the health agency confident that the current safety limits for cellphone radiation protect the public health.

Plus, FDA pointed out confusing findings from the rodent study — such as that the radiated rats lived longer than comparison rats that weren’t exposed to the rays. The toxicology agency said it appeared that the radio frequency energy helped older rats’ kidneys.

There’s a reason two different government agencies are clashing — they’re asking different questions, said George Washington University public health professor George Gray.

 

Cellphone
The Food and Drug Administration, which oversees cellphone safety, disagreed with the upgraded warning. And “these findings should not be applied to human cellphone usage Pixabay

 

A former science chief for the Environmental Protection Agency, Gray said the toxicology program examined how cellphone radiation affected animals. By looking at what it means for humans, the FDA “brings in more sources of information and data than just these recent tests in rats and mice,” he said in an email.

So are cellphones safe?

“I’m calling you from my cellphone,” noted the cancer society’s Brawley.

He pointed out one well-known risk from cellphones: Car crashes when drivers are distracted by them.

Also Read: Aggressive Treatment Of Prostate Cancer May Also Lead To Usage Of Anti-Depressants: Study

As for cancer, if people are concerned, they could use earphones or speakers, he said.

Those who study risk aren’t hanging up.

“My family and I won’t change our mobile phone habits based on this news,” said George Washington’s Gray, co-author of the book “Risk: A Practical Guide for Deciding What’s Really Safe and What’s Really Dangerous in the World Around You.” (VOA)

Next Story

Researchers Discover Balance of Two Enzymes That May Help Treat Pancreatic Cancer

While still in the earliest stages, Newton hoped this information might one day aid pancreatic diagnostics and treatment

0
Cancer
Cancer Ribbon. Pixabay

A new research has set the stage for clinicians to potentially use levels of a pancreatic cancer patient’s PHLPP1 and PKC enzymes as a prognostic and for researchers to develop new therapeutic drugs that change the balance of the two enzymes as a means to treat the disease.

The study, published on Wednesday in Molecular Cell, was led by Alexandra Newton, professor in the Department of Pharmacology at the University of California, San Diego, School of Medicine, and Timothy Baffi, a graduate student in her lab, Xinhua news agency reported.

The new study built on the team’s work in 2015 that found the enzyme PKC, which was believed in previous studies to promote tumour growth, actually suppressed it.

The latest study took the investigation a step further by uncovering how cells regulate PKC activity and discovered that any time an over-active PKC is inadvertently produced, the PHLPP1 “proofreader” tags it for destruction.

Cancer patient
Cancer patient.

“That means the amount of PHLPP1 in your cells determines your amount of PKC,” Newton said. “And it turns out those enzyme levels are especially important in pancreatic cancer.”

The team observed 105 pancreatic cancer tumours to analyze the enzyme levels in each one. About 50 per cent of patients with low PHLPP1/high PKC lived longer than five-and-a-half years.

Also Read- A Brain Circuit Can Help Reverse Craving for Liquor, Says Study

While still in the earliest stages, Newton hoped this information might one day aid pancreatic diagnostics and treatment.

Pancreatic cancer is caused by the abnormal and uncontrolled growth of cells in the pancreas, a large gland in the digestive system. It typically doesn’t show symptoms in the early stages. Sufferers tend to develop signs, such as back pain and jaundice, when it has spread to other organs. (IANS)